Cargando…
Daily Costs and Cost Effectiveness of Glaucoma Fixed Combinations in China
BACKGROUND: The aim of this study was to compare the daily costs and cost effectiveness of fixed combination glaucoma drugs in China. METHODS: This study included the following fixed combination drugs: brinzolamide 1% and timolol 0.5% (Azarga; Alcon, Inc., Fort Worth, TX, USA), travoprost 0.004% and...
Autores principales: | Xu, Chenjia, Guo, Ruru, Huang, Dandan, Ji, Jian, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436355/ https://www.ncbi.nlm.nih.gov/pubmed/32850141 http://dx.doi.org/10.1155/2020/2406783 |
Ejemplares similares
-
Identification and functional analysis of a novel missense mutation in GJA8, p.Ala69Thr
por: Li, Dandan, et al.
Publicado: (2020) -
Transscleral cyclophotocoagulation followed by cataract surgery: a novel protocol to treat refractory acute primary angle closure
por: Liu, Wei, et al.
Publicado: (2020) -
Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
por: Bergström, Anders, et al.
Publicado: (2009) -
Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
por: Lan, Ying, et al.
Publicado: (2023) -
Pathological Changes of the Anterior Lens Capsule
por: Liu, Wei, et al.
Publicado: (2021)